Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Leiomyosarcoma<br />
J. Cheville<br />
Definition<br />
Leiomyosarcoma is a rare malignant<br />
mesenchymal tumour that arises from<br />
urinary bladder smooth muscle.<br />
ICD-O code 8890/3<br />
Epidemiology and etiology<br />
Although leiomyosarcoma is the most<br />
common sarcoma of the urinary bladder it<br />
accounts for much less than 1% of all<br />
bladder malignancies. Males are more frequently<br />
affected than females by over 2:1<br />
{1639,1734,2543}. This sarcoma occurs<br />
primarily in adults in their 6th to 8th<br />
decade. Several cases of leiomyosarcoma<br />
of the bladder have occurred years after<br />
cyclophosphamide therapy {2039,2253}.<br />
Localization<br />
Leiomyosarcoma can occur anywhere<br />
within the bladder, and very rarely can<br />
involve the ureter or renal pelvis {947,<br />
1816}.<br />
Clinical features<br />
The vast majority of patients present with<br />
haematuria, and on occasion, a palpable<br />
pelvic mass, abdominal pain or urinary<br />
tract obstruction may be present.<br />
Macroscopy<br />
Leiomyosarcoma of the urinary bladder<br />
is typically a large, infiltrating mass with a<br />
mean size of 7 cm. High grade leiomyosarcoma<br />
frequently exhibits gross and<br />
microscopic necrosis.<br />
Histopathology<br />
Histopathologic examination reveals a<br />
tumour composed of infiltrative interlacing<br />
fascicles of spindle cells. Grading of<br />
leiomyosarcoma is based on the degree<br />
of cytologic atypia. Low grade leiomyosarcoma<br />
exhibits mild to moderate cytologic<br />
atypia, and has mitotic activity less<br />
than 5 mitoses per 10 HPF. In contrast,<br />
high grade leiomyosarcoma shows<br />
marked cytologic atypia, and most cases<br />
have greater than 5 mitoses per 10 HPF.<br />
Immunohistochemically, leiomyosarcoma<br />
stains with antibodies directed against<br />
actin, desmin and vimentin, and are negative<br />
for epithelial markers {1410,1639,<br />
1734,2817}.<br />
Leiomyoma can be morphologically separated<br />
from leiomyosarcoma based on<br />
its small size, low cellularity, circumscription,<br />
and lack of cytologic atypia {1639}.<br />
Reactive spindle cell proliferations such<br />
as inflammatory pseudotumour or postoperative<br />
spindle cell nodule/tumour can<br />
be difficult to distinguish from leiomyosarcoma<br />
{1572,2889}. Leiomyosarcoma<br />
exhibits greater cytologic atypia, abnormal<br />
mitoses, and an arrangement in<br />
compact cellular fascicles in contrast to<br />
reactive spindle cell proliferations, which<br />
have a loose vascular myxoid background.<br />
However, myxoid change can<br />
occur in leiomyosarcoma {2899}.<br />
Sarcomatoid carcinoma can resemble<br />
leiomyosarcoma but is usually associated<br />
with a malignant epithelial component<br />
or exhibits cytokeratin positivity.<br />
Prognosis<br />
Although previous reports suggest that<br />
5-year survival after partial or radical cystectomy<br />
approaches 70%, the largest<br />
recent study indicates that 70% of<br />
patients with leiomyosarcoma developed<br />
recurrent or metastatic disease, resulting<br />
in death in nearly half {1639}.<br />
Fig. 2.75 Leiomyosarcoma of the bladder.<br />
Fig. 2.76 Bladder leiomyosarcoma.<br />
140 Tumours of the urinary system